Related Experiment Videos
[Genetic polymorphism of drug metabolizing enzymes]
1Institute of Pharmaceutical Sciences, Hokkaido University, Sapporo.
Seikagaku. the Journal of Japanese Biochemical Society
|February 12, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes.
Xenobiotica; the fate of foreign compounds in biological systems·2009
Polymer-induced phase separation in aqueous micellar solutions of octyl-beta-D-thioglucoside for extraction of membrane proteins.
Biotechnology and bioengineering·2008
CYP2C76-mediated species difference in drug metabolism: a comparison of pitavastatin metabolism between monkeys and humans.
Xenobiotica; the fate of foreign compounds in biological systems·2006
Species differences in hydrolase activities toward OT-7100 responsible for different bioavailability in rats, dogs, monkeys and humans.
Xenobiotica; the fate of foreign compounds in biological systems·2006
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
Cancer chemotherapy and pharmacology·2006
Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
Xenobiotica; the fate of foreign compounds in biological systems·2005
Geographical Access to Preferred Pharmacies in Medicare Part D.
The American journal of managed care·2026
Artificial intelligence-enabled causal estimate of Medicare drug plan integration in cancer care: A doubly robust machine learning instrumental variable analysis.
Journal of managed care & specialty pharmacy·2026
Long-Acting Injectable Antiretroviral Therapies for HIV Treatment and Prevention: Clinical Pharmacology, Recent Advances and Future Opportunities.
Journal of clinical pharmacology·2026
When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026